kugerageza kuvura kanseri y'ibihaha

Kwivura Kanseri yibihaha: Ubuyobozi bwuzuyeGusobanukirwa imiterere ya kugerageza kuvura kanseri y'ibihaha amahitamo ni ngombwa kubarwayi n'imiryango yabo. Iyi ngingo itanga incamake yubuvuzi bugezweho, bugaragaza inyungu zabo, aho zigarukira, hamwe nubuyobozi bwubushakashatsi. Tuzasesengura uburyo butandukanye bwo kuvura, dushimangira akamaro ko kwitabwaho kugiti cyawe no kugerageza kwa kliniki.

Ubwoko bwo kuvura Kanseri yibihaha

Ubuvuzi bugamije

Ubuvuzi bugamije kwibanda ku buryo budasanzwe bwo mu ngirabuzimafatizo ziri mu ngirabuzimafatizo za kanseri, bigatuma busobanuka neza kuruta imiti gakondo. Ubu buvuzi bushobora kuba bukubiyemo tyrosine kinase inhibitor (TKIs) yibanda ku ihinduka ryihariye nka EGFR, ALK, ROS1, na BRAF. Ingaruka zo kuvura zigamije ziratandukanye cyane bitewe numwirondoro wihariye wumurwayi. Kurugero, kanseri y'ibihaha ya EGFR ihindagurika ikunze kwitabira EGFR TKIs nka gefitinib cyangwa erlotinib. Ariko, kurwanya birashobora gutera imbere mugihe, bisaba guhindura ingamba zo kuvura. Igeragezwa rya Clinical rihora risuzuma uburyo bushya bwo kuvura hamwe nuburyo bwo guhuza uburyo bwo gutsinda ibitagenda neza. Wibuke guhora muganira kuburyo bwo kuvura hamwe na oncologue wawe, kuko birashobora kukuyobora kuri gahunda iboneye ukurikije ibihe byihariye.

Immunotherapy

Immunotherapie ikoresha imbaraga z'umubiri bwite wo kurwanya kanseri. Immune igenzura (ICIs), nka pembrolizumab na nivolumab, ihagarika poroteyine zibuza ingirabuzimafatizo kwirinda kanseri. Ubu bwoko bwa kugerageza kuvura kanseri y'ibihaha yerekanye intsinzi idasanzwe mu barwayi bamwe, biganisha ku gukira igihe kirekire mu bihe bimwe na bimwe. Nyamara, abarwayi bose ntabwo bitabira immunotherapy, kandi ingaruka zirashobora kuba ingirakamaro. Abashakashatsi barimo gushakisha byimazeyo uburyo bwo kunoza imikorere n’umutekano wa immunotherapie, harimo no kubihuza n’ubundi buvuzi nka chimiotherapie cyangwa imiti igamije.

Virusi ya Oncolytike

Virusi ya Oncolytike ni virusi zakozwe na genetique zanduza kandi zangiza selile za kanseri mugihe zisize ingirabuzimafatizo nziza. Ubu buryo buracyari mu ntangiriro yiterambere rya kanseri y'ibihaha, ariko bwerekana ibisubizo bitanga umusaruro mubushakashatsi bwibanze ndetse no kwipimisha hakiri kare. Ubushobozi bwubu bwoko bwa kugerageza kuvura kanseri y'ibihaha iri mubushobozi bwayo bwo kwibasira no kwica selile kanseri kandi birashobora gutera ubudahangarwa bw'umubiri kurwanya ikibyimba.

CAR T-selile

Chimeric antigen reseptor (CAR) T-selile yubuvuzi ikubiyemo guhindura selile T umurwayi kugirango amenye kandi atere kanseri. Ubu buryo bwihariye bwerekanye intsinzi idasanzwe muri kanseri zimwe na zimwe z'amaraso, ariko iracyakurikiranwa. Igeragezwa rya Clinical rirakomeje kugirango harebwe umutekano n’akamaro ko kuvura CAR T-selile mu bwoko butandukanye bwa kanseri y'ibihaha. Harakenewe ubushakashatsi bwinshi kugirango umenye uruhare rwayo mugace kavura kanseri y'ibihaha.

Guhitamo uburyo bwiza bwo kuvura

Guhitamo igikwiye kugerageza kuvura kanseri y'ibihaha bisaba gutekereza cyane kubintu byinshi, harimo ubuzima bwumurwayi muri rusange, icyiciro nubwoko bwa kanseri yibihaha, hamwe ninyungu zishobora guterwa na buri buryo bwo kuvura. Itsinda ry’inzobere zitandukanye, zirimo abaganga ba oncologue, abaganga babaga, radiologue, n’abandi bahanga mu by'ubuzima, ubusanzwe bakorera hamwe kugira ngo bategure gahunda yo kuvura umuntu ku giti cye. Kugira uruhare mu igeragezwa ry’amavuriro birashobora gutanga uburyo bwo kuvura udushya kandi bikagira uruhare mu guteza imbere ubushakashatsi bwa kanseri. Ni ngombwa kugirana ibiganiro byeruye kandi byukuri hamwe nitsinda ryanyu ryita ku buzima kugirango ufate ibyemezo byuzuye. Gusobanukirwa ubushakashatsi buheruka no gukomeza kumenyeshwa uburyo bushya bwo kuvura ni ngombwa mu kuyobora uru rugendo rugoye. Kubindi bisobanuro ninkunga, urashobora gutekereza kubikoresho nkikigo cyigihugu cya kanseri (NCI) cyangwa ishyirahamwe ryibihaha ryabanyamerika.

Ibigeragezo bya Clinical nubushakashatsi

Uruhare mu igeragezwa ryamavuriro rutanga uburyo bugezweho kugerageza kuvura kanseri y'ibihahas kandi itanga amakuru yingirakamaro kugirango turusheho gutera imbere umurima. Ikigo cy’igihugu cya kanseri (NCI) gikora imibare yuzuye y’ibizamini by’amavuriro, bitanga ibisobanuro birambuye ku bijyanye n’ibipimo byujuje ibisabwa ndetse n’ibigo byitabira. Ibigo byinshi, harimo na Shandong Baofa Ikigo Cy’ubushakashatsi cya Kanseri (https://www.baofahospital.com/), bagira uruhare rugaragara mubushakashatsi bwa kanseri y'ibihaha kandi bagaha abarwayi amahirwe yo kwitabira ibizamini byo kwa muganga. Izi manza zikora iperereza ku buvuzi bushya, zigashakisha uburyo bwiza bwo kuvura busanzwe, kandi bugakora ubushakashatsi ku buryo bwo kuzamura imibereho y’abafite iyi ndwara. Mbere yo kwiyandikisha mu rubanza, ni ngombwa kumva neza inzira, inyungu zishobora kubaho n'ingaruka, hamwe n'ubwitange burimo.

Imbonerahamwe: Incamake yubuvuzi bwa Kanseri yibihaha

Ubwoko bwo kuvura	Urwego	Inyungu Zishobora	Imipaka
Ubuvuzi bugamije	Intego yihariye ihindagurika ryimiterere	Ingaruka nziza muri mutation yihariye, ingaruka nke ugereranije na chimiotherapie	Iterambere ryo kurwanya, ntabwo rifite akamaro kubarwayi bose
Immunotherapy	Yongera ubudahangarwa bw'umubiri kurwanya kanseri	Kwakira igihe kirekire mubarwayi bamwe	Ntabwo ari ingirakamaro kubarwayi bose, ingaruka zikomeye zirashoboka
Virusi ya Oncolytike	Virusi yakozwe na genetike yibasira selile	Kurimbura guhitamo ingirabuzimafatizo za kanseri	Intambwe yambere yiterambere, ingaruka ndende ntizwi
CAR T-selile	T selile yahinduwe yibasira kanseri	Ingaruka nziza muri kanseri zimwe na zimwe z'amaraso, ubushobozi bwo kuvura kanseri y'ibihaha	Intambwe yambere yiterambere rya kanseri yibihaha, ingaruka zishobora kubaho

Inshingano: Aya makuru agenewe intego zuburezi gusa kandi ntagomba gufatwa nkinama zubuvuzi. Buri gihe ujye ubaza abashinzwe ubuzima kugirango basuzume kandi bavurwe.